Ledger.Open graph →
SEC Form D · Amendment · filed November 26, 2024

Optimeos Life Sciences, Inc

Offering
$5.0M
Sold
$2.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PRINCETON, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Robert K. Prud'Homme, Phd · Princeton, NJExec · DirectorBenjamin K. Doranz · Princeton, NJDirectorShahram Hejazi, Phd · Princeton, NJExec · DirectorJason K. Smith, Phd · Princeton, NJDirectorRobert K. Prud'Homme, Phd · Princeton, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗